Evidence map›Paper›PMID 41656526›Full record

ArticleJournal of biomedical materials research. Part A2026

Controlled Antibiotic Release From Emulsion-Loaded Alginate and Fibrin Hydrogels Using Ultrasound.

Ziba Ghareh Nazi Fam, Asia Winslow, Mario L Fabiilli, Sam Varghese, Brian E Oeffinger, Flemming Forsberg, Noreen J Hickok, Lauren J Delaney

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part A, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Ziba Ghareh Nazi FamDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-7441-5282
Asia WinslowDepartment of Orthopedic Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Mario L FabiilliDepartment of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
Sam VargheseDepartment of Radiology, University of Michigan, Ann Arbor, Michigan, USA.
Brian E OeffingerDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.
Flemming ForsbergDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.ORCID 0000-0003-2215-1371
Noreen J HickokDepartment of Orthopedic Surgery, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.ORCID 0000-0001-8501-2817
Lauren J DelaneyDepartment of Radiology, Thomas Jefferson University, Philadelphia, Pennsylvania, USA.

Funding

Ultrasound-Triggered Prophylaxis as a Novel Paradigm for Preventing Spinal InfectionR00AR078354 · NIAMS · THOMAS JEFFERSON UNIVERSITY · PI DELANEY, LAUREN JO · 2022 to 2024
$740k
NIAMS NIH HHS R00 AR078354NIH HHS R00AR078354Thomas Jefferson University
6 · The paper itself

Abstract

Postoperative infections remain a major complication after spinal fusion surgery, often caused by biofilm-forming bacteria that resist short-term antibiotic prophylaxis. Vancomycin (VAN) is sometimes delivered locally during surgery; however, levels diminish rapidly, leaving patients vulnerable to late-onset infections. We developed a composite hydrogel integrating perfluorohexane-based emulsions within alginate or fibrin matrices to enable both sustained and ultrasound-triggered VAN release. Water-in-oil-in-water emulsions were prepared using fluorosurfactant-stabilized perfluorohexane as the volatile oil phase, then embedded in hydrogels and exposed to ultrasound (2.5 MHz, 5.5 MPa peak negative pressure) to initiate acoustic droplet vaporization for triggered release. Drug release was quantified spectrophotometrically and with fluorescent-labeled VAN, while antibacterial efficacy was tested against Staphylococcus aureus. Hydrogels directly loaded with free VAN exhibited burst release (~55%-67% within 24 h) followed by limited sustained release, which is suboptimal for prolonged coverage. In contrast, emulsion-loaded hydrogels reduced premature leakage, retaining > 70% VAN on Day 1 and providing gradual baseline release. Ultrasound application enhanced VAN release up to 8.75-fold in alginate and 27.5-fold in fibrin hydrogels after 7 days (p < 0.0001), supporting both continuous and on-demand delivery. Only alginate-emulsion hydrogels showed measurable antibacterial activity, as drug-matrix interactions in fibrin prevented release; ultrasound-treated samples displayed significantly greater efficacy over 7 days (p < 0.05 vs. no ultrasound). This dual-mode delivery platform enables spatial and temporal control of VAN release, combining early prophylaxis with ultrasound-triggered reinforcement, and holds promise for improving infection prevention in orthopedic surgeries by aligning drug delivery with clinical timelines.

Indexed as

AlginatesAnti-Bacterial AgentsFibrinHydrogelsUltrasonic WavesVancomycinDelayed-Action PreparationsDrug LiberationEmulsionsGlucuronic AcidHexuronic AcidsStaphylococcus aureusAlginatesAnti-Bacterial AgentsDelayed-Action PreparationsEmulsionsFibrinGlucuronic AcidHexuronic AcidsHydrogelsVancomycinalginatecontrolled releasefibrinphase‐shift emulsionsultrasound

Identifiers

PMID41656526
PMCPMC13636844

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.